6 Oct 2026Shukra Pharmaceuticals Ltd board approves allotment of 17,35,000 equity shares upon conversion of warrants on preferential basisCapital Raise
29 Sept 2026Shukra Pharmaceuticals Ltd AGM outcome on 28 Sep 2026; voting results for 4 resolutions including FY26 financialsRecord Date
29 Sept 2026Shukra Pharmaceuticals Ltd postal ballot voting results for amendment in MOA object clause on 26 Sep 2026Record Date
28 Sept 2026Shukra Pharmaceuticals Ltd proceedings of 33rd AGM held on 28 Sep 2026Record Date
22 Sept 2026Shukra Pharmaceuticals Ltd issues corrigendum to Postal Ballot Notice dated 22 Aug 2026 for name change and MOA alterationRecord Date
3 Sept 2026Shukra Pharmaceuticals Ltd reschedules 33rd AGM to 28 Sep 2026 and revises book closure datesRecord Date
3 Sept 2026Shukra Pharmaceuticals Ltd declares final dividend of ₹0.01 per share; record date 21 Sep 2026Record Date
27 Aug 2026Shukra Pharmaceuticals Ltd postal ballot notice with voting period from 28 Aug 2026 to 26 Sep 2026Record Date
22 Aug 2026Shukra Pharmaceuticals Ltd board meeting outcome on 22 Aug 2026 approving name change to Shukra Medtech and convening 33rd AGMKMP
7 May 2026Shukra Pharmaceuticals Limited Annual Secretarial Compliance Report for FY26 under Regulation 24A filed on 07 May 2026Audit Reports
